Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-02-28 1:2:53 pm | Xilio Therapeutics to Participate in Novel Immuno-Oncology Panel at TD Cowen 44th Annual Health Care Conference | GlobeNewsWire |
| 2024-01-31 1:1:0 pm | Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference | GlobeNewswire |
| 2024-01-08 4:30:0 am | Xilio Therapeutics Highlights Recent Advances Across Clinical Pipeline and Encouraging Preliminary Phase 1 Safety Data for XTX301, a Tumor-Activated IL-12, Further Validating the Promise of Its Tumor-Activated Immuno-Oncology Therapies | GlobeNewswire |
| 2023-12-07 4:30:0 am | Xilio Therapeutics Announces Initiation of Enrollment for Phase 1 Combination Trial of XTX101, a Tumor-Activated, Fc-Enhanced Anti-CTLA-4, and Updated Phase 1 Monotherapy Data | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information